NR3C1 encodes the glucocorticoid receptor (GR) and regulates stress responses, metabolism, immune function, and inflammation, ...
Punjab’s Drugs Control Directorate warns that lab tests found three medicines substandard or adulterated. Authorities order ...
Results from the MagnetisMM-5 study showed that Elrexfio significantly improved progression-free survival, which means ...
Oculis Holding AG recently completed the final patient visits in its two Phase 3 DIAMOND trials of OCS-01, a topical dexamethasone eye drop being studied over 52 weeks as a potential first ...
Pfizer announces positive results from phase 3 MagnetisMM-5 study of Elrexfio as monotherapy in adults with relapsed or refractory multiple myeloma: New York Thursday, April 30, 2 ...
Pfizer Inc. today announced positive topline results from the Phase 3 MagnetisMM-5 study evaluating ELREXFIO® (elranatamab) as monotherapy in adults with relapsed or refractory multiple myeloma (RRMM) ...
Latest findings from the DME AWARE Delphi Study on unmet needs in diabetic macular edema (DME) management highlighting the need for non-invasive ...
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 MagnetisMM-5 study evaluating ELREXFIO® (elranatamab) as monotherapy ...
Phase 3 MagnetisMM-5 trial data in multiple myeloma highlight progression-free survival gains and key safety considerations ...
The Phase 3 MagnetisMM-5 trial showed that elranatamab (ELREXFIO) significantly improved progression-free survival versus ...
Oncology nurse practitioners discuss CD38-based frontline therapy for newly diagnosed multiple myeloma, including Dara-VRd ...
Semaglutide is a drug used for type 2 diabetes, weight loss, and more. Oral tablets and injections are both effective ways to take semaglutide. Oral tablets do not require the use of needles, but you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results